Skip to main content

Ajovy News

Teva Announces FDA Approval of Ajovy (fremanezumab-vfrm) Injection Autoinjector

PARSIPPANY, N.J.--(BUSINESS WIRE) January 28, 2020 – Teva Pharmaceuticals USA, Inc. an affiliate ofTeva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the Food and Drug...

FDA Approves Ajovy (fremanezumab-vfrm) for Preventive Treatment of Migraine

September 14, 2018 – Today, the US Food and Drug Administration (FDA) approved Ajovy (fremanezumab-vfrm) for the preventive treatment of migraine in adults. Ajovy is the second FDA-approved...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Migraine Prevention, Migraine Prophylaxis

Ajovy patient information at Drugs.com